In leukemias, miR-150-5p act as a tumor suppressor in MLL-rearranged and other subtypes of acute myeloid leukemia (AML), by targeting HOXA9 and MEIS1, either directly or indirectly [23, 33]. Here, HOXA9 is linked to leukemia.